Comprehensive Cancer Centers

Las Vegas, Nevada 89169

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Excluding Breast Cancer, Advanced Well-differentiated Neuroendocrine Tumors, Castration Resistant Prostate Adenocarcinoma, Diffuse Large B Cell Lymphoma, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Ovarian Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, PI3K Pathway Activated Tumors, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

Studies at this site

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — Recruiting now
• Study of HL-085 in Patients With Advanced Solid Tumor Tumors — Completed
• PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies — Completed
• Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors — Completed
• BKM120 for Patients With PI3K-activated Tumors — Completed